Search

Your search keyword '"Murray, Ruth"' showing total 438 results

Search Constraints

Start Over You searched for: Author "Murray, Ruth" Remove constraint Author: "Murray, Ruth"
438 results on '"Murray, Ruth"'

Search Results

2. The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia

3. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

4. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

5. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

6. Patterns of care in the management of high-risk COPD in the US (2011–2019): an observational study for the CONQUEST quality improvement program

7. Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study

8. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

9. Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort.

11. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort

12. Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry

13. Potential Severe Asthma Hidden in UK Primary Care

14. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

16. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry

17. International Severe Asthma Registry: Mission Statement

18. Longitudinal patterns of intermittent oral corticosteroid use for asthma in the UK

19. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

20. Children and Global Diversity: Collaborative Development of Learning Materials

21. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

22. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

23. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

24. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

25. Adult Severe Asthma Registries: A Global and Growing Inventory

27. Identifying opportunities for earlier diagnosis of high-risk COPD patients in Australia: an observational study

28. International severe asthma registry (ISAR): protocol for a global registry

29. The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia.

30. MURRAY, RUTH

31. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air approach.

32. Adult Severe Asthma Registries: A Global and Growing Inventory

33. Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER):Data From the International Severe Asthma Registry

34. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

35. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

36. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

37. Comparative effectiveness of anti‐IL5 and anti‐IgE biologic classes in patients with severe asthma eligible for both

38. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

39. The ARIA-MASK-air® approach

40. Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both

41. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy

42. Diabolical Diabetes (Diabetes Mellitus)

43. Asthma exacerbations are associated with a decline in lung function: a longitudinal population based study.

45. Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study

46. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

47. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy

48. Real World Biologic Use and Switch Patterns in Severe Asthma:Data from the International Severe Asthma Registry and the US CHRONICLE Study

49. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy

50. CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients

Catalog

Books, media, physical & digital resources